Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 7 days
Any time
Past hour
Past 24 hours
Past 30 days
Most recent
Best match
sicklecellanemianews
3d
At times, stepping back from advocacy is the wise thing to do
Columnist Mary Shaniqua, returning from her post-wedding activities, has learned that stepping back from advocacy obligations ...
sicklecellanemianews
4d
Stroke rate rising for adults, children with SCD in US: Study
The stroke rate among adults and children with sickle cell disease in the U.S. is rising, indicating a need for greater ...
sicklecellanemianews
6d
Pfizer withdraws Oxbryta from global markets, cites safety concerns
Pfizer withdrew Oxbryta (voxelotor), a conditionally approved oral therapy for SCD, saying its benefits don't outweigh risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Mexican mayor assassinated
Ranger dies during rescue
Milton becomes Category 5
Fans throw objects on field
Musk's X appeal rejected
American sentenced in RU
Ring ceremony canceled
Vanderbilt, Arkansas fined
Faces assault, drug charges
Supreme Court rejects bid
Ukraine strikes RU oil hub
North Dakota wildfires
Father-son duo make history
Novelist Robert Coover dies
Canyoneering fall death
Names new school board
Record military aid to Israel
TX emergency abortion case
Hamas strikes Tel Aviv
SCOTUS new term begins
Mark Oct 7 anniversary
Another top aide resigns
R. Kelly's appeal declined
IVF clinic's appeal rejected
Launches asteroid probe
GA abortion ban reinstated
Feedback